-
U.S. Senators Mel Martinez (R-FL) and Evan Bayh (D-IN) introduced a measure to create a collaborated system for researching, treating and eliminating Alzheimer's disease. The proposal will create an Office of the National Alzheimer's Project within the White House, and will coordinate all research, clinical care and service toward the ...
-
Memory is a fundamental function of nerve cells in the brain, and loss of memory is a key symptom in many people with Alzheimer's disease. In order for memory to function correctly, nerve cells must be able to communicate effectively with each other. Many important proteins in the brain ensure ...
-
Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning, which become severe enough to impede social or occupational functioning. Alzheimer's disease is also known as simply Alzheimer's, and Senile Dementia of the ...
-
Today there are an estimated 5.3 million Americans with Alzheimer's disease. Although the majority of Alzheimer cases are individuals age 65 and older, there is still a significant number of individuals under age 65 impacted by this fatal disease that today has no cure. For people under age 65 with ...
-
Most parts of living organisms come packaged with ribbons. The ribbons are proteins - chains of amino acids that must fold into three-dimensional structures to work properly. But when for any reason the ribbons fold incorrectly, bad things can happen, and in humans misfolded-protein disorders include Alzheimer's and Parkinson's diseases....
-
New research has uncovered an early disruption in the process of memory formation in older humans who exhibit some early brain changes associated with Alzheimer's disease (AD) but show little or no memory impairment. The work, published by Cell Press in the July 30th issue of the journal Neuron, sheds ...
-
With just $399 and a bit of saliva in a cup, consumers can learn about their genetic risk for diseases from breast cancer to Alzheimer's. Now, thanks to social networking sites set up by personal genomics companies, they can also share that information with family, friends and even strangers on ...
-
Applied NeuroSolutions, Inc. (OTC BB:APSN), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), announced it has achieved promising results in its development of a blood-based test related to the diagnosis of patients with Alzheimer's disease (AD)....
-
In a new study published today in the July issue of the journal Cell Host & Microbe, UC Davis researchers report that both amyloid plaques found in the brains of Alzheimer's patients and structures made by some gut bacteria likely elicit the same response by human immune cells. "Alzheimer's disease ...
-
The UK will play a leading role in coordinated European action to tackle dementia from. A new initiative launched by the European Commission has adopted proposals to tackle Alzheimer's disease, dementias and other neurodegenerative conditions. The UK is one of ten countries that will lead research aimed at tackling shared ...
-
A study led by Johns Hopkins and Utah State University researchers suggests that a particularly close relationship with caregivers may give people with Alzheimer's disease a marked edge over those without one in retaining mind and brain function over time. The beneficial effect of emotional intimacy that the researchers saw ...
-
A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine....
-
Several cerebrospinal fluid (CSF) biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer disease, according to a study in the July 22/29 issue of JAMA. Alzheimer disease (AD) is the most common cause of dementia, affecting more than 15 million individuals worldwide. Because of ...
-
Critical Outcome Technologies Inc. (COTI)(TSX VENTURE:COT), announced that the Company has undertaken the discovery and optimization of novel lead compounds for the treatment of Alzheimer's Disease (AD). "Based on partnering interest expressed by multiple global pharmaceutical organizations we have decided to establish a drug discovery program to help combat this ...
-
An initiative from the Government's National Dementia Strategy, the summit will examine research into cause, cure and care, highlighting gaps in knowledge and new opportunities for the future. A report will then be produced to help shape the future dementia research agenda....
-
Discoveries by Scripps Research Institute scientists have led to a promising new drug candidate - the first in its class - for patients with a genetic protein-misfolding disease. In results announced by the biopharmaceutical firm FoldRx Pharmaceuticals, Inc., the new drug tafamidis significantly halts disease progression for patients with a ...
-
The UK needs a national plan for dementia research or the country will pay the price, the UK's top scientists are warning today. In a letter to the government 31 leading dementia researchers united to call for a national plan for dementia research and a tripling of current investment. The ...
-
Over 30 of the UK's leading scientists have signed an open letter to the government calling for more public money to back research into dementia, warning that UK's weakness was "lack of funding, not lack of talent" and in order to make up for "years of underfunding" there should be ...
-
UC Irvine scientists have shown for the first time that neural stem cells can rescue memory in mice with advanced Alzheimer's disease, raising hopes of a potential treatment for the leading cause of elderly dementia that afflicts 5.3 million people in the U.S. Mice genetically engineered to have Alzheimer's performed ...
-
Research carried out at the Hebrew University of Jerusalem has resulted in a promising approach to help treat Alzheimer's disease in a significant proportion of the population that suffers from a particularly rapid development of this disease....
